Literature DB >> 12530947

Etiology and management of fulminant hepatic failure.

Javier Vaquero1, Andres T Blei.   

Abstract

Fulminant hepatic failure (FHF) remains a rare but devastating disease. Viruses and drug-induced hepatotoxicity are the most common causes of the syndrome, but the relevance of each differs depending on the geographic area. In a large proportion of patients no cause for FHF can be identified. Good intensive care is critical for patient survival. Orthotopic liver transplantation (OLT) remains a definitive therapeutic option. Prognostic indices have helped to optimize patient selection and timing for performance of OLT. However, the accuracy of these prognostic indices decreases when they are applied to different populations, probably because of regional differences in etiology and peculiar native host factors. More accurate prognostic criteria and new therapeutic alternatives to OLT are required.

Entities:  

Mesh:

Year:  2003        PMID: 12530947     DOI: 10.1007/s11894-003-0008-8

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  49 in total

1.  Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure.

Authors:  A J Ellis; R D Hughes; J A Wendon; J Dunne; P G Langley; J H Kelly; G T Gislason; N L Sussman; R Williams
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

2.  Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization.

Authors:  P Traber; M DalCanto; D Ganger; A T Blei
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

Review 3.  Fulminant and subfulminant liver failure: definitions and causes.

Authors:  J Bernuau; B Rueff; J P Benhamou
Journal:  Semin Liver Dis       Date:  1986-05       Impact factor: 6.115

4.  Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure.

Authors:  S Miwa; Y Hashikura; A Mita; T Kubota; H Chisuwa; Y Nakazawa; T Ikegami; M Terada; S Miyagawa; S Kawasaki
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

5.  Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries.

Authors:  Bjørn Brandsaeter; Krister Höckerstedt; Styrbjörn Friman; Bo-Göran Ericzon; Preben Kirkegaard; Helena Isoniemi; Michael Olausson; Ulrika Broome; Lars Schmidt; Aksel Foss; Kristian Bjøro
Journal:  Liver Transpl       Date:  2002-11       Impact factor: 5.799

Review 6.  The American experience with transplantation for acute liver failure.

Authors:  T M McCashland; B W Shaw; E Tape
Journal:  Semin Liver Dis       Date:  1996-11       Impact factor: 6.115

7.  Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin.

Authors:  J O Clemmesen; B A Hansen; F S Larsen
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

8.  Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France.

Authors:  C Féray; M Gigou; D Samuel; J Bernuau; H Bismuth; C Bréchot
Journal:  J Hepatol       Date:  1993-04       Impact factor: 25.083

9.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

Authors:  J G O'Grady; A E Gimson; C J O'Brien; A Pucknell; R D Hughes; R Williams
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

10.  Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure.

Authors:  J M Salmerón; L Titó; A Rimola; A Mas; M A Navasa; J Llach; A Ginès; P Ginès; V Arroyo; J Rodés
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

View more
  14 in total

1.  Risk factors for alcoholic liver disease in China.

Authors:  Xiao-Lan Lu; Jin-Yan Luo; Ming Tao; Yan Gen; Ping Zhao; Hong-Li Zhao; Xiao-Dong Zhang; Nei Dong
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  SOCS3 expression correlates with severity of inflammation in mouse hepatitis virus strain 3-induced acute liver failure and HBV-ACLF.

Authors:  Yong Li; Mei-Fang Han; Wei-Na Li; Ai-Chao Shi; Yuan-Ya Zhang; Hong-Yan Wang; Fa-Xi Wang; Lan Li; Ting Wu; Lin Ding; Tao Chen; Wei-Ming Yan; Xiao-Ping Luo; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

3.  Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.

Authors:  Giuseppina Basta; Serena Del Turco; Teresa Navarra; William M Lee
Journal:  Liver Transpl       Date:  2015-06       Impact factor: 5.799

4.  Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure.

Authors:  Kazuhiro Kotoh; Masaki Kato; Motoyuki Kohjima; Masatake Tanaka; Masayuki Miyazaki; Kazuhiko Nakamura; Munechika Enjoji; Makoto Nakamuta; Ryoichi Takayanagi
Journal:  Exp Ther Med       Date:  2011-01-19       Impact factor: 2.447

5.  CD69+NK cells contribute to the murine hepatitis virus strain 3-induced murine hepatitis.

Authors:  Lin Ding; Tao Chen; Xiao-Jing Wang; Li Zhou; Ai-Chao Shi; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

6.  Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice.

Authors:  Justin H Nguyen; Satoshi Yamamoto; Jeffery Steers; Daniel Sevlever; Wenlang Lin; Naoki Shimojima; Monica Castanedes-Casey; Petrina Genco; Todd Golde; Elliott Richelson; Dennis Dickson; Michael McKinney; Christopher B Eckman
Journal:  J Hepatol       Date:  2005-11-07       Impact factor: 25.083

7.  Mir-24 regulates hepatocyte apoptosis via BIM during acute liver failure.

Authors:  Zhiwen Feng; Zhi Li; Deming Zhu; Wei Ling; Lei Zheng; Liyong Pu; Lianbao Kong
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure.

Authors:  Naoki Shimojima; Christopher B Eckman; Michael McKinney; Daniel Sevlever; Satoshi Yamamoto; Wenlang Lin; Dennis W Dickson; Justin H Nguyen
Journal:  J Invest Surg       Date:  2008 May-Jun       Impact factor: 2.533

9.  A Study of Hepatitis E in Pregnancy: Maternal and Fetal Outcome.

Authors:  Gowri Sayi Prasad; Sayi Prasad; Ashok Bhupali; Ajit N Patil; Kanishtha Parashar
Journal:  J Obstet Gynaecol India       Date:  2015-08-22

10.  TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure.

Authors:  Satoshi Yamamoto; Justin H Nguyen
Journal:  J Surg Res       Date:  2006-02-20       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.